With our in-house technology platform, scientific expertise in the inner ear, and network of experts, Sensorion can continually develop and optimize its pipeline and market expertise. Consequently, we are poised to expand our pipeline and facilitate other pharmaceutical collaborations.

We select and develop drug candidates from a pool of compounds in late pre-clinical and clinical stage development obtained from partnerships, collaborations and publically available drug libraries.

20201104 Pipeline


Latest news

  • 07 Jan 2021

    Sensorion announces initiation of coverage by investment banks Jefferies and Kempen with a “Buy” recommendation. Read

  • 05 Jan 2021

    Sensorion provides an update on plans and progress in the development of SENS-401 for the prevention of hearing loss. Read

Patient center

Corporate presentation